An Official Website of the United States Government
Company Information:
Name:
INDEVR, INC.
Address:
2100 Central Ave, Suite 106
BOULDER, CO 80301-
BOULDER, CO 80301-
Located in HUBZone:
No
Woman-Owned:
Yes
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Advanced Detection Technologies for Biochips
Award Year / Program / Phase:
2004 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF COLORADO AT BOULDER
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of the proposed work is the development of innovative detection technologies for biochips (a.k.a. DNA microarrays). It is envisioned that the proposed technologies will enable the application of biochips to biodefense, particularly when a… More
Monitoring System For Vector-Based Influenza Vaccine
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Matthew M. Ferris
Award Amount:
$597,544.00
Abstract:
DESCRIPTION (provided by applicant): This Advanced Technology proposal is in response to NIAID's recently issued Notice of High-Priority Influenza Research Areas [NOT-AI-05-013]. In order to provide health officials with the tools required to efficiently combat a pandemic strain of influenza, it is… More
Monitoring System For Vector-Based Influenza Vaccine
Award Year / Program / Phase:
2008 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Award Amount:
$2,401,162.00
Abstract:
DESCRIPTION (provided by applicant): This Phase II Advanced Technology SBIR [PA-06-134] proposal is in response to NIAID's Notice of High-Priority Influenza Research Areas [NOT-AI-05-013]. In order to provide health officials with the tools required to eff
iciently combat a pandemic strain of… More
SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$597,128.00
Abstract:
DESCRIPTION (provided by applicant): Our objective is to develop a commercially viable influenza diagnostic for rapid and simultaneous screening of clinical samples for influenza A and B type and important subtypes. The advantages of the proposed approach
over existing polymerase chain reaction… More
SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Erica D. Dawson – 303-402-9100
Award Amount:
$2,988,813.00
Abstract:
DESCRIPTION (provided by applicant): The objective for this Phase II application is to develop a cartridge-based automated molecular diagnostic platform to rapidly and cost-effectively detect and identify influenza viruses. The system will automate all keyfunctions for sample processing including… More
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Kathy L. Rowlen – 303-402-9100
Award Amount:
$600,000.00
Abstract:
DESCRIPTION (provided by applicant): There is a tremendous need for new analytical methods to enhance vaccine research and development, ultimately allowing the production of safe and efficacious vaccines in less time at less cost. For example, it is well known that for splt vaccines one step in the… More